chrX-102937957-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001031834.1(RAB40AL):c.639G>A(p.Pro213=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00285 in 1,210,336 control chromosomes in the GnomAD database, including 71 homozygotes. There are 906 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 38 hom., 443 hem., cov: 23)
Exomes 𝑓: 0.0016 ( 33 hom. 463 hem. )
Consequence
RAB40AL
NM_001031834.1 synonymous
NM_001031834.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.17
Genes affected
RAB40AL (HGNC:25410): (RAB40A like) This gene encodes a member of the Rab40 subfamily of Rab small GTP-binding proteins that contains a C-terminal suppressors of cytokine signaling box. Disruptions in this gene are associated with Duchenne muscular dystrophy. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant X-102937957-G-A is Benign according to our data. Variant chrX-102937957-G-A is described in ClinVar as [Benign]. Clinvar id is 618337.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.17 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0505 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB40AL | NM_001031834.1 | c.639G>A | p.Pro213= | synonymous_variant | 1/1 | ENST00000218249.7 | NP_001027004.1 | |
LINC00630 | NR_146589.1 | n.1910-20691G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB40AL | ENST00000218249.7 | c.639G>A | p.Pro213= | synonymous_variant | 1/1 | NM_001031834.1 | ENSP00000218249 | P1 | ||
ENST00000413528.1 | n.441C>T | non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0151 AC: 1695AN: 112059Hom.: 38 Cov.: 23 AF XY: 0.0129 AC XY: 443AN XY: 34221
GnomAD3 genomes
AF:
AC:
1695
AN:
112059
Hom.:
Cov.:
23
AF XY:
AC XY:
443
AN XY:
34221
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00460 AC: 845AN: 183506Hom.: 19 AF XY: 0.00290 AC XY: 197AN XY: 67934
GnomAD3 exomes
AF:
AC:
845
AN:
183506
Hom.:
AF XY:
AC XY:
197
AN XY:
67934
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00160 AC: 1753AN: 1098228Hom.: 33 Cov.: 32 AF XY: 0.00127 AC XY: 463AN XY: 363588
GnomAD4 exome
AF:
AC:
1753
AN:
1098228
Hom.:
Cov.:
32
AF XY:
AC XY:
463
AN XY:
363588
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0151 AC: 1696AN: 112108Hom.: 38 Cov.: 23 AF XY: 0.0129 AC XY: 443AN XY: 34280
GnomAD4 genome
AF:
AC:
1696
AN:
112108
Hom.:
Cov.:
23
AF XY:
AC XY:
443
AN XY:
34280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 22, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at